Search Tag: Vasopressin

ICU Management

Cardiovascular-management-in-septic-shock-optimising-vascular-and-cardiac-function

2023 30 Nov

An overview of vasopressor management, current evidence on its use, when to initiate vasopressor therapy for best possible patient outcome and a discussion regarding the use of landiolol in septic patients with persistent tachycardia.    Optimising Vasopressin Initiation in Septic Shock   Patients with septic shock, and especially...Read more

ICU Management

Cardiovascular-management-in-sepsis-improving-cardiac-and-vascular-functions

2023 13 Oct

Vasopressin and landiolol are critical therapies for ensuring the vascular and cardiac systems are as close to optimal conditions as possible during septic shock. Better cardiovascular management in septic shock can help improve septic shock management.     Sepsis is a life-threatening organ dysfunction caused by a dysregulated host response...Read more

ICU Management

Improving-haemodynamic-management-of-icu-patients-decatecholaminisation-cardiac-stress-reduction

2022 08 Dec

A summary of a symposium organised by AOP Health with presentations from Ricard Ferrer, Vall d’Hebron University Hospital, Barcelona, Spain; Bruno Levy, Centre Hospitalier Universitaire de Nancy, CHU Nancy · Réanimation Médicale Brabois, France; and Michael Fries, St. Vincenz Krankenhaus Limburg, Department of Anesthesiology, Germany....Read more

ICU Management

Isicem22-vasodilatory-choice-and-timing

2022 25 Mar

An article released in conjunction with the Intensive Care & Emergency Medicine (ISICEM) Congress helps clinicians understand the choice and timing of vasopressors in vasodilatory shock. It is one of ten reviews selected from the Annual Update in Intensive Care and Emergency Medicine 2022.  Vasodilatory shock is one of the most common forms encountered...Read more

ICU Management

Vasopressin-reduces-septic-shock-deaths-but

2019 18 Mar

A Chinese research team performed a meta-analysis and trial sequential analysis of randomised controlled trials (RCTs) evaluating the effects of vasopressin receptor agonists in septic shock patients. Their findings show the use of vasopressin might result in reduced mortality in these patients, but an increased risk of digital ischaemia must be taken...Read more